Cannabis leaf together with chemical molecules representing cannabidiol (CBD) as an alternative in scientific studies on epilepsy.

Scientists confirm efficacy of cannabidiol in a type of genetic epilepsy

A study published in Epilepsia shows that pharmaceutical cannabidiol (CBD) can significantly reduce seizures in monogenic epilepsies, a rare and difficult-to-treat type of epilepsy. The research, conducted in Europe and Latin America, provides solid scientific evidence for the efficacy and safety of CBD in these genetic conditions.

Scientists confirm efficacy of cannabidiol in a type of genetic epilepsy Read More »